상세정보
- 상세정보
Mesothelioma From Research to Clinical Practice [electronic resource]
Ceresoli, Giovanni Luca
- 책이미지
-
- 도서 상세정보
- 서평쓰기
| 자료유형 | 단행본 |
|---|---|
| 개인저자 | Ceresoli, Giovanni Luca.,editor. Bombardieri, Emilio.,editor. D'Incalci, Maurizio.,editor. |
| 단체저자명 | SpringerLink (Online service). |
| 서명/저자사항 | Mesothelioma [electronic resource] : From Research to Clinical Practice / edited by Giovanni Luca Ceresoli, Emilio Bombardieri, Maurizio D'Incalci. |
| 판사항 | 1st ed. 2019. |
| 형태사항 | XII, 340 p. 82 illus., 56 illus. in color:online resource. |
| 기본자료 저록 | Springer Nature eBook |
| 기타형태 저록 | Printed edition:9783030168834Printed edition:9783030168858Printed edition:9783030168865 |
| ISBN | 9783030168841 |
| 기타표준부호 | 10.1007/978-3-030-16884-1 |
| 내용주기 | Epidemiology of mesothelioma -- Asbestos and pathophysiology of mesothelioma -- Screening issues in exposed subjects and early diagnosis -- Genetics and epigenetics of mesothelioma -- Microenvironment and immunology of mesothelioma -- Pre clinical models in mesothelioma -- Pathological diagnosis of mesothelioma -- Tissue and circulating biomarkers in mesothelioma -- Diagnostic imaging of mesothelioma -- Measuring malignant pleural mesothelioma -- Role of metabolic imaging in mesothelioma -- Staging of malignant pleural mesothelioma -- Surgery and multimodality treatment in malignant pleural mesothelioma -- Role of radiotherapy in malignant pleural mesothelioma -- Role of chemotherapy in malignant pleural mesothelioma -- Targeting angiogenesis in mesothelioma -- Targeted therapies in mesothelioma -- Mesothelin-targeting agents in mesothelioma -- Immunotherapy of mesothelioma: vaccines and cell therapy -- Immunotherapy of mesothelioma: immune checkpoints inhibitors -- Peritoneal mesothelioma: diagnosis and management -- Rare localizations of mesothelioma -- Unmet needs and future outlook of mesothelioma management. |
| 요약 | This book offers an updated review of malignant mesothelioma, including the latest advances in our understanding of its genetic control and molecular biology, as well as pre-clinical and clinical research. It also presents state-of-the-art diagnostic approaches and therapeutic options, and an open discussion on the future prospects for patient management. Malignant mesothelioma is an enormous global health problem related to asbestos exposure. Despite the best efforts of scientists and oncologists, the prognosis for those affected remains poor. Due to anatomical characteristics and non-specific symptoms, the diagnosis of mesothelioma at an early stage is often difficult, while surgery and radiotherapy are only of limited use, even if some multimodality approaches seem promising. In turn, medical treatments are sometimes successful in tumor control, but have little impact on overall survival. However, advances in our understanding of the disease’s biology, together with the availability of new drugs and combinations, make mesothelioma an essential and highly topical field for pre-clinical and clinical studies. This book is subdivided into four parts: epidemiology and preclinical data, diagnosis, therapy, and extrathoracic mesothelioma. It highlights the progress made in a variety of areas – e.g. in vitro and in vivo experimental models, genetics, environment, biomarkers, targeting agents, immunotherapy, metabolic imaging and ongoing clinical trials – and describes the standard clinical management of mesothelioma patients, including those with extra-thoracic localizations. Given its scope, the book offers an invaluable tool for researchers, oncologists and clinicians alike. |
| 일반주제명 | Oncology. Nuclear medicine. Medicine—Research. Biology—Research. Bioinformatics. Medical genetics. Immunology. Oncology. Nuclear Medicine. Biomedical Research. Bioinformatics. Medical Genetics. Immunology. |
| 바로가기 | URL |